The RNA binding protein HuR does not interact directly with HIV-1 reverse transcriptase and does not affect reverse transcription in vitro

Retrovirology

Volumn 7, Issue , 2010, Pages

  Ahn, Jinwoo ^a   Byeon, In Ja L ^a   Dharmasena, Sanjeewa ^a   Huber, Kelly ^a   Concel, Jason ^a   Gronenborn, Angela M ^a   Sluis Cremer, Nicolas ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUR PROTEIN; RNA DIRECTED DNA POLYMERASE; ELAV-LIKE PROTEIN 1; MEMBRANE ANTIGEN; RECOMBINANT PROTEIN; REVERSE TRANSCRIPTASE, HUMAN IMMUNODEFICIENCY VIRUS 1; RNA BINDING PROTEIN; VIRUS RNA;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DNA SYNTHESIS; HETERONUCLEAR SINGLE QUANTUM COHERENCE; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; REVERSE TRANSCRIPTION; VIRUS REPLICATION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR CLONING; NUCLEAR MAGNETIC RESONANCE; PHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN MULTIMERIZATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ANTIGENS, SURFACE; CLONING, MOLECULAR; HIV REVERSE TRANSCRIPTASE; HIV-1; HUMANS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN INTERACTION MAPPING; PROTEIN MULTIMERIZATION; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTION; RNA, VIRAL; RNA-BINDING PROTEINS;

EID: 77951948273     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-7-40     Document Type: Article

References (34)

1. Aiken C, Trono D. Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. J Virol 1995, 69:5048-5056. 189322, 7541845.
2. Goncalves J, Korin Y, Zack J, Gabuzda D. Role of Vif in human immunodeficiency virus type 1 reverse transcription. J Virol 1996, 70:8701-8709. 190965, 8970997.
3. Harrich D, Ulich C, García-Martínez LF, Gaynor RB. Tat is required for efficient HIV-1 reverse transcription. EMBO J 1997, 16:1224-1235. 10.1093/emboj/16.6.1224, 1169721, 9135139.
4. Kiernan RE, Ono A, Englund G, Freed EO. Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle. J Virol 1998, 72:4116-4126. 109641, 9557701.
5. Wu X, Liu H, Xiao H, Conway JA, Hehl E, Kalpana GV, Prasad V, Kappes JC. Human immunodeficiency virus type 1 integrase protein promotes reverse transcription through specific interactions with the nucleoprotein reverse transcription complex. J Virol 1999, 73:2126-2135. 104457, 9971795.
6. Weiss S, König B, Morikawa Y, Jones I. Recombinant HIV-1 nucleocapsid protein p15 produced as a fusion protein with glutathione S-transferase in Escherichia coli mediates dimerization and enhances reverse transcription of retroviral RNA. Gene 1992, 121:203-212. 10.1016/0378-1119(92)90123-7, 1280240.
7. Kohlstaedt LA, Wang J, Friedman JM, Rice PA, Steitz TA. Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science 1992, 256:1783-1790. 10.1126/science.1377403, 1377403.
8. König R, Zhou Y, Elleder D, Diamond TL, Bonamy GM, Irelan JT, Chiang CY, Tu BP, De Jesus PD, Lilley CE, Seidel S, Opaluch AM, Caldwell JS, Weitzman MD, Kuhen KL, Bandyopadhyay S, Ideker T, Orth AP, Miraglia LJ, Bushman FD, Young JA, Chanda SK. Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 2008, 135:49-60. 10.1016/j.cell.2008.07.032, 2628946, 18854154.
9. Lemay J, Maidou-Peindara P, Bader T, Ennifar E, Rain JC, Benarous R, Liu LX. HuR interacts with human immunodeficiency virus type 1 reverse transcriptase, and modulates reverse transcription in infected cells. Retrovirology 2008, 5:47-61. 10.1186/1742-4690-5-47, 2441633, 18544151.
10. Lemay J, Maidou-Peindara P, Cancio R, Ennifar E, Coadou G, Maga G, Rain JC, Benarous R, Liu LX. AKAP149 binds to HIV-1 reverse transcriptase and is involved in the reverse transcription. J Mol Biol 2008, 383:783-796. 10.1016/j.jmb.2008.08.055, 18786546.
11. Warrilow D, Meredith L, Davis A, Burrell C, Li P, Harrich D. Cell factors stimulate human immunodeficiency virus type 1 reverse transcription in vitro. J Virol 2008, 82:1425-1437. 10.1128/JVI.01808-07, 2224456, 18045931.
12. Tabah A, Tardiff K, Mansky L. Characterization of a novel TRIM protein that possesses anti-HIV-1 activity [abstract]. 16th Conference on Retroviruses and Opportunistic Infections, February 8-11, 2009. Montreal, Canada
13. Liu J, Dalmau J, Szabo A, Rosenfeld M, Huber J, Furneaux H. Paraneoplastic encephalomyelitis antigens bind to the AU-rich elements of mRNA. Neurology 1995, 45:544-550.
14. Ma WJ, Cheng S, Campbell C, Wright A, Furneaux H. Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein. J Biol Chem 1996, 271:8144-8151. 10.1074/jbc.271.14.8144, 8626503.
15. Meisner NC, Hackermüller J, Uhl V, Aszódi A, Jaritz M, Auer M. mRNA openers and closers: modulating AU-rich element-controlled mRNA stability by a molecular switch in mRNA secondary structure. Chembiochem 2004, 5:1432-1447. 10.1002/cbic.200400219, 15457527.
16. López de Silanes I, Zhan M, Lal A, Yang X, Gorospe M. Identification of a target RNA motif for RNA-binding protein HuR. Proc Natl Acad Sci USA 2004, 101:2987-2992. 10.1073/pnas.0306453101, 365732, 14981256.
17. Fialcowitz-White EJ, Brewer BY, Ballin JD, Willis CD, Toth EA, Wilson GM. Specific protein domains mediate cooperative assembly of HuR oligomers on AU-rich mRNA-destabilizing sequences. J Biol Chem 2007, 282:20948-20959. 10.1074/jbc.M701751200, 2244793, 17517897.
18. Meisner NC, Hintersteiner M, Mueller K, Bauer R, Seifert JM, Naegeli HU, Ottl J, Oberer L, Guenat C, Moss S, Harrer N, Woisetschlaeger M, Buehler C, Uhl V, Auer M. Identification and mechanistic characterization of low-molecular-weight inhibitors for HuR. Nat Chem Biol 2007, 3:508-515. 10.1038/nchembio.2007.14, 17632515.
19. Bodenhausen G, Ruben DJ. Natural abundance nitrogen-15 NMR by enhanced hetero-nuclear spectroscopy. Chem Phys Lett 1980, 69:185-189.
20. Mori S, Abeygunawardana C, Johnson MO, Vanzijl PCM. Improved Sensitivity of HSQC Spectra of Exchanging Protons at Short Interscan Delays Using a New Fast HSQC (FHSQC) Detection Scheme That Avoids Water Saturation. J Magn Reson Series B 1995, 108:194-98.
21. Brehm JH, Mellors JW, Sluis-Cremer N. Mechanism by which a glutamine to leucine substitution at residue 509 in the ribonuclease H domain of HIV-1 reverse transcriptase confers zidovudine resistance. Biochemistry 2008, 47:14020-14027. 10.1021/bi8014778, 2740331, 19067547.
22. Sluis-Cremer N, Arion D, Parikh U, Koontz D, Schinazi RF, Mellors JW, Parniak MA. The 3'-azido group is not the primary determinant of 3'-azido-3'-deoxythymidine (AZT) responsible for the excision phenotype of AZT-resistant HIV-1. J Biol Chem 2005, 280:29047-29052. 10.1074/jbc.M503166200, 15970587.
23. Michihiko S, Yamamoto N, Shinozaki F, Shimada K, Soma G, Kobayashi N. Augmentation of in-vitro HIV replication in peripheral blood mononuclear cells of AIDS and ARC patients by tumor necrosis factor. Lancet 1989, 27:1206-1207.
24. Mellors JW, Griffith BP, Ortiz MA, Landry ML, Ryan JL. Tumor necrosis factor-alpha/cachectin enhances human immunodeficiency virus type 1 replication in primary macrophages. J Infect Dis 1991, 163:78-82.
25. Li Q, Gebhard K, Schacker T, Henry K, Haase AT. The relationship between tumor necrosis factor and human immunodeficiency virus gene expression in lymphoid tissue. J Virol 1997, 71:7080-7082. 192000, 9261439.
26. Lane BR, Markovitz DM, Woodford NL, Rochford R, Strieter RM, Coffey MJ. TNF-alpha inhibits HIV-1 replication in peripheral blood monocytes and alveolar macrophages by inducing the production of RANTES and decreasing C-C chemokine receptor 5 (CCR5) expression. J Immunol 1999, 163:3653-3661.
27. Seko Y, Cole S, Kasprzak W, Shapiro BA, Ragheb JA. The role of cytokine mRNA stability in the pathogenesis of autoimmune disease. Autoimmun Rev 2006, 5:299-305. 10.1016/j.autrev.2005.10.013, 16782553.
28. Kim HH, Yang X, Kuwano Y, Gorospe M. Modification at HuR(S242) alters HuR localization and proliferative influence. Cell Cycle 2008, 7:3371-3377. 2704553, 18948743.
29. Kim HH, Abdelmohsen K, Lal A, Pullmann R, Yang X, Galban S, Srikantan S, Martindale JL, Blethrow J, Shokat KM, Gorospe M. Nuclear HuR accumulation through phosphorylation by Cdk1. Genes Dev 2008, 22:1804-1815. 10.1101/gad.1645808, 2492667, 18593881.
30. Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, Xavier RJ, Lieberman J, Elledge SJ. Identification of host proteins required for HIV infection through a functional genomic screen. Science 2008, 319:921-926. 10.1126/science.1152725, 18187620.
31. Zhou H, Xu M, Huang Q, Gates AT, Zhang XD, Castle JC, Stec E, Ferrer M, Strulovici B, Hazuda DJ, Espeseth AS. Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe 2008, 4:495-504. 10.1016/j.chom.2008.10.004, 18976975.
32. Ahn J, Byeon IJ, Byeon CH, Gronenborn AM. Insight into the structural basis of pro- and antiapoptotic p53 modulation by ASPP proteins. J Biol Chem 2009, 284:13812-13822. 10.1074/jbc.M808821200, 19246451.
33. Le Grice SF, Cameron CE, Benkovic SJ. Purification and characterization of human immunodeficiency virus type 1 reverse transcriptase. Methods Enzymol 1995, 262:130-144. full_text, 8594344.
34. Le Grice SF, Gruninger-Leitch F. Rapid purification of homodimer and heterodimer HIV-1 reverse transcriptase by metal chelate affinity chromatography. Eur J Biochem 1990, 187:307-314. 10.1111/j.1432-1033.1990.tb15306.x, 1688798.